Takeaways From Largest Drug Safety Settlement

Law360, New York (June 14, 2013, 12:07 PM EDT) -- On May 13, 2013, generic drug manufacturer Ranbaxy USA Inc., a subsidiary of Indian generic drug manufacturer Ranbaxy Laboratories Limited, pleaded guilty to seven felony charges as part of a global settlement pursuant to which Ranbaxy will pay a total of $500 million to resolve criminal and civil False Claims Act liability.[1]

In pleading guilty, Ranbaxy admitted to manufacturing and distributing adulterated drugs made at two of Ranbaxy’s facilities in Ponta Sahib and Dewas, India, failing to file required reports with the U.S. Food and Drug...
To view the full article, register now.